REFARMA
ActiveSummary
REFARMA has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €10,918. Equity remains stable across the filed financial years (±0.7% per year). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-09
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 61 days late
2025
31-12
Financial
Highest result from 2018 to 2025net €10,918 ▲11%
Net result €10,918, the highest in the series.
28-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 28 days late
2024
30-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 30 days late
2023
31-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 31 days late
2022
14-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
27-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 27 days late
2020
05-10
NBB filing
Annual accounts filed
financial year 2019 · micro format · 66 days late
2019
05-08
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format · 5 days late
2018
27-08
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format · 27 days late
2017
24-08
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 36 annual accounts filed, the latest 10 are here; all are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.